ADA and psychotic disorder: Finding that measuring serum ADA levels can distinguish schizophrenia patients and patient relatives from healthy controls is particularly significant as ADA represents an objective biochemical marker, minimizing researcher-related biases, and offers a simple, practical, and potentially valuable tool for establishing psychosis susceptibility.